(S (PP (IN In) (NP (DT this) (NN paper))) (, ,) (NP (PRP we)) (VP (VBP seek) (NP (DT a) (ADJP (RB clinically) (HYPH -) (JJ relevant)) (NN latent) (NN code)) (PP (IN for) (S (VP (VBG representing) (NP (NP (DT the) (NN spectrum)) (PP (IN of) (NP (JJ macular) (NN disease)))))))) (. .))
(S (PP (IN Towards) (NP (DT this) (NN end))) (, ,) (NP (PRP we)) (VP (VBP construct) (NP (NP (ADJP (NP (NP (NN retina) (HYPH -) (NN VAE)) (, ,) (NP (DT a) (JJ variational) (NN autoencoder))) (HYPH -) (VBN based)) (NN model) (SBAR (WHNP (WDT that)) (S (VP (VBZ accepts) (NP (DT a) (JJ patient) (NN profile) (NN vector))))) (PRN (-LRB- -LRB-) (NP (NN pVec)) (-RRB- -RRB-))) (PP (IN as) (NP (NN input))))) (. .))
(S (NP (DT The) (NN pVec) (NNS components)) (VP (VBP include) (NP (NP (JJ clinical) (NN exam) (NNS findings)) (CC and) (NP (JJ demographic) (NN information)))) (. .))
(S (NP (PRP We)) (VP (VBP evaluate) (NP (DT the) (NN model)) (PP (IN on) (NP (NP (DT a) (NN subspectrum)) (PP (IN of) (NP (NP (DT the) (JJ retinal) (NNS maculopathies)) (, ,) (PP (IN in) (NP (JJ particular) (, ,) (JJ exudative) (ADJP (NN age) (HYPH -) (VBN related)) (JJ macular) (NN degeneration))) (, ,) (NP (JJ central) (JJ serous) (NN chorioretinopathy)) (, ,) (CC and) (NP (JJ polypoidal) (JJ choroidal) (NN vasculopathy))))))) (. .))
(S (PP (IN For) (NP (DT these) (CD three) (NNS maculopathies))) (, ,) (NP (NP (DT a) (NN database)) (PP (IN of) (NP (NP (CD 3000) (ADJP (NP (CD 6)) (HYPH -) (JJ dimensional)) (NNS pVecs)) (-LRB- -LRB-) (NP (NP (CD 1000)) (NP (DT each))) (-RRB- -RRB-)))) (VP (VBD was) (ADVP (RB synthetically)) (VP (VBN generated) (PP (VBN based) (PP (IN on) (NP (NP (JJ known) (NN disease) (NNS statistics)) (PP (IN in) (NP (DT the) (NN literature)))))))) (. .))
(S (NP (DT The) (NN database)) (VP (VP (VBD was) (ADVP (RB then)) (VP (VBN used) (S (VP (TO to) (VP (VB train) (NP (DT the) (NN VAE))))))) (CC and) (VP (VBP generate) (NP (NN latent) (NN vector) (NNS representations)))) (. .))
(S (NP (PRP We)) (VP (VBD found) (NP (NN training) (NN performance)) (S (VP (TO to) (VP (VB be) (ADJP (ADJP (JJS best)) (PP (IN for) (NP (NP (DT a) (ADJP (CD 3) (HYPH -) (JJ dimensional)) (NN latent) (NN vector) (NN architecture)) (PP (VBN compared) (PP (IN to) (NP (ADJP (QP (CD 2) (CC or) (CD 4)) (JJ dimensional)) (NNS latents))))))))))) (. .))
(S (ADVP (RB Additionally)) (, ,) (PP (IN for) (NP (DT the) (NN 3D) (NN latent) (NN architecture))) (, ,) (NP (PRP we)) (VP (VBD discovered) (SBAR (IN that) (S (NP (DT the) (VBG resulting) (NN latent) (NNS vectors)) (VP (VBD were) (ADJP (RB strongly) (JJ clustered)) (PP (ADVP (RB spontaneously)) (IN into) (NP (NP (CD one)) (PP (IN of) (NP (CD 14) (NNS clusters))))))))) (. .))
(S (NP (NNP Kmeans)) (VP (VBD was) (ADVP (RB then)) (VP (VBN used) (ADVP (RB only)) (S (VP (VP (TO to) (VP (VB identify) (NP (NP (NNS members)) (PP (IN of) (NP (DT each) (NN cluster)))))) (CC and) (VP (TO to) (VP (VB inspect) (NP (NN cluster) (NNS properties)))))))) (. .))
(S (NP (DT These) (NNS clusters)) (VP (VBP suggest) (NP (NP (VBG underlying) (NN disease) (NNS subtypes)) (SBAR (WHNP (WDT which)) (S (VP (MD may) (ADVP (RB potentially)) (VP (VB respond) (UCP (ADVP (RB better)) (CC or) (ADJP (JJR worse) (PP (IN to) (NP (NP (JJ particular) (JJ pharmaceutical) (NNS treatments)) (PP (JJ such) (IN as) (NP (JJ anti-vascular) (NML (JJ endothelial) (NN growth) (NN factor)) (NNS variants))))))))))))) (. .))
(S (NP (DT The) (NML (NN retina) (HYPH -) (NN VAE)) (NN framework)) (VP (MD will) (ADVP (RB potentially)) (VP (VB yield) (NP (JJ new) (JJ fundamental) (NNS insights)) (PP (IN into) (NP (NP (DT the) (NNS mechanisms) (CC and) (NNS manifestations)) (PP (IN of) (NP (NN disease))))))) (. .))
(S (CC And) (VP (MD will) (ADVP (RB potentially)) (VP (VB facilitate) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (VBN personalized) (NNS pharmaceuticals) (CC and) (NN gene) (NNS therapies)))))) (. .))
